Ajooni Biotech Ltd

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 July 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 01 Jan 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Ajooni Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, posted its quarterly results for March 2026, reflecting a positive yet cautious financial trend. While net sales reached a record high, margin pressures and profitability challenges have tempered investor enthusiasm, leading to a downgrade in the company’s Mojo Grade from Strong Sell to Sell.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis below reflects the stock's current fundamentals, returns, and financial metrics as of 21 April 2026, providing investors with an up-to-date perspective on the company’s position in the Pharmaceuticals & Biotechnology sector.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 01 Jan 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Ajooni Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating change occurred at the start of the year, the analysis and financial metrics discussed here reflect the company’s current position as of 16 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company's standing in the Pharmaceuticals & Biotechnology sector.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with the latest insights into its performance and outlook.

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.